Pricing Log in Create free account

CytoMed Therapeutics Limited (GDTC) vs Intensity Therapeutics Inc. (INTS)

CytoMed Therapeutics Limited and Intensity Therapeutics Inc. are both Biotechnology companies. CytoMed Therapeutics Limited and Intensity Therapeutics Inc. are of similar size ($10.4M and $10.1M). Across the 9 metrics below, CytoMed Therapeutics Limited leads on 6 and Intensity Therapeutics Inc. on 3.

Valuation

Metric GDTC INTS Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 0.55 0.87 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.12 0.65
EV/Sales n/m n/m 8.98
Earnings yield (32.94%) (164.06%) (34.89%)
Free cash flow yield (0.40%) (111.37%) (24.52%)

Profitability

Metric GDTC INTS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (195.88%) (50.12%)
Return on assets 0.00% (139.85%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GDTC INTS Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (68.75%) 70.74% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC INTS Biotechnology median
Debt to equity 80.30 0.01 0.00
Current ratio 2.64 5.00 4.89
Net debt to EBITDA 0.86 0.99 1.01

Dividend

Metric GDTC INTS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GDTC INTS Biotechnology median
Market cap 10.41m 10.12m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack